Thoracoscopic sympathectomy for isolated XXXX .

@entity1 @entity3190 @entity2652 @entity913
BACKGROUND: @entity2652 is one of the most peculiar of @entity1 expressions and has become a cardinal symptom of @entity913 . The pathophysiology is unclear and the prevalence is unknown. Thoracoscopic sympathectomy may cure the symptom, but very few surgeons treat @entity1 with isolated @entity2652 . The literature is limited, and there are few long-term follow-up studies. METHODS: A follow-up study by questionnaire in 180 consecutive @entity1 who underwent thoracoscopic sympathectomy for isolated @entity2652 at two Danish university hospitals during a 6-year period. @entity1 routinely underwent T2 sympathectomy at the university hospital in Aarhus (n = 101) and T2-T3 sympathectomy at the university hospital in Odense (n = 79). RESULTS: The questionnaire was returned by 96% of the @entity1 after a median follow-up time of 20 months. Overall, 90% of the @entity1 had some effect from the operation, and the result was excellent or satisfactory in 75%. There was no significant difference between the two extents of sympathectomy. @entity3190 occurred in 88% of all @entity1 and was significantly more frequent after T2-T3 sympathectomy (p = 0.02) Ten percent of our @entity1 regretted the operation because of side effects or no effect of the operation. CONCLUSIONS: This study demonstrates that thoracoscopic sympathectomy is an effective treatment for isolated @entity2652 . The majority of @entity1 achieve an excellent or satisfactory long-term result. Our results suggest that a T2 sympathectomy is superior for @entity1 with isolated @entity2652 because side effects are lower compared with a T2-T3 sympathectomy.
